Consumer Medication Information: Expert and Consumer Evaluation of Consumer Medication Information‐2008

A study released today by the U.S. Food and Drug Administration found that the printed consumer medication information (CMI) voluntarily provided with new prescriptions by retail pharmacies does not consistently provide easy-to-read, understandable information about the use and risks of medications.

• Expert and Consumer Evaluation of Consumer Medication Information - 2008 Final Report [PDF]
• Executive Summary [PDF]
• FDA Statement
• Docket: "Expert and Consumer Evaluation of Consumer Medication Information -- 2008." Open until June 1, 2009. To submit public comments, click on “Add Comments” in the far right column.
• Federal Register Notice for the February, 2009 Risk Communication Advisory Committee meeting. 
• Questions and Answers
• Consumer Update: Prescription Drug Leaflets Need Improvement
• Chart: Types of Patient Information [PDF]

Background Information

• Action Plan for the Provision of useful Prescription Medicine Information (Keystone Report) [PDF]
• Drug Safety and Risk Management Advisory Committee meeting [PDF], 7/17/2002
• Guidance: Useful Written Consumer Medication Information (CMI) [PDF]